Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease
EYE-TAR(MA)
1 other identifier
observational
8
0 countries
N/A
Brief Summary
This study aims to evaluate impacts of an emotion recognition rehabilitation program, named Training of Affect Recognition, on social cognition abilities in Alzheimer's disease (AD). In addition, we hypothesis that the effect of this rehabilitation will also evolve gaze strategies, behavioral disorders, and the caregiver's burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2020
CompletedFirst Submitted
Initial submission to the registry
January 26, 2021
CompletedFirst Posted
Study publicly available on registry
January 29, 2021
CompletedJanuary 29, 2021
January 1, 2021
1.1 years
January 26, 2021
January 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Facial emotion recognition (FER) performances
Change from Baseline and Comparison of FER performance between AD-TAR group and AD-Cognitive Stimulation group. Evaluation criteria: Scores to Ekman Faces task (1976) and time to answer. FER was assessed using pictures from the Ekman Faces task (1976), to test the recognition of the six facial basic emotions and neutral faces. There were four pictures per emotion, for a total of 28. For each picture, participants were asked to select one of the seven labels (anger, disgust, fear, sadness, happiness, surprise and neutral), with a maximum of 8 seconds of response time per picture.
Baseline; Week 6; 1 month post intervention
Affective ToM performances
Change from Baseline and Comparison of Affective ToM performance between AD-TAR group and AD-Cognitive Stimulation group. Evaluation criteria: Scores to the " Reading the Mind in the Eyes " test (Baron-Cohen 2001). 36 black-and-white photographs of the eye area of faces. Subjets are asked to choose which word, among four options, best described what the character in the photograph was thinking or feeling. For this task, four scores were obtained: a total score (/36) and three emotional valence sub-scores: positive (/8), neutral (/16) and negative (/12).
Baseline; Week 6; 1 month post intervention
Secondary Outcomes (4)
Eye gaze strategies during Facial emotion recognition (FER)
Baseline; Week 6; 1 month post intervention
Behavioral disorders
Baseline; Week 6; 1 month post intervention
The Family caregiver's burden
Baseline; Week 6; 1 month post intervention
Global cognitive performance
Baseline; Week 6; 1 month post intervention
Study Arms (2)
AD-TAR
AD subjects who take part to Facial Emotion Recognition rehabilitation (TAR)
AD-Cognitive Stimulation
AD subjects who take part to cognitive stimulation session (12 sessions during 4 weeks)
Interventions
Intervention description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using a rehabilitation program named Training of Affect Recognition (TAR).
Intervention description: 12 sessions in groups of 4 subject, over 6 weeks (2 sessions per week), using classic cognitive stimulation workshops.
Eligibility Criteria
Patient with an Alzheimer's disease and with a Mini-Mental State score ≥15
You may qualify if:
- AD diagnosed according to l'IWG-2 (Dubois \& al. 2014) criteria,
- Mini-Mental State (MMS-E) ≥15
- Subject accompanied by a family caregiver and whose participation in a cognitive stimulation workshop was recommended in Memory Centre of the RAINIER Centre (Princesses Grace Hospital - Monaco)
- Written informed consent signed by patient and family caregiver.
You may not qualify if:
- General anaesthesia within 3 months.
- Ophthalmological or neurological problems preventing a video-oculography examination.
- Oculomotor disorders such as "fixation disorders" or "ocular tracking disorders".
- Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia.
- History of bipolar disorder or schizophrenia
- History of alcohol abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2021
First Posted
January 29, 2021
Study Start
March 1, 2019
Primary Completion
March 26, 2020
Study Completion
March 26, 2020
Last Updated
January 29, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share